Atlas Trials

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

Clinical trial NCT04943627 · WITHDRAWN

Trial details

NCT number
NCT04943627
Sponsor
Agenus Inc.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced CancerMetastatic Cervical Cancer
Start date
2021-08-02
Primary completion
2021-10-22
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.